Public Policy Resources

Share

As a recognized expert in cancer health policy, ACS CAN develops reports, white papers, testimony, fact sheets, regulatory comment letters and public policy on a wide range of issues related to preventing cancer and improving the health care system for persons with cancer and survivors.  We encourage you to use this resource to learn more about our issue priorities and policy work. If you can't find something you need, you may contact us by using our contact form and selecting Policy Resources from the drop-down menu.

Search for Resources

FILTER BY:

Photo of female cancer patient

Patient Quality of Life

ACS CAN advocates for policies that improve the lives of cancer patients by making treatment of their pain and other symptoms and coordination of their care standard protocol throughout their treatment for cancer, starting at the point of diagnosis.
 

Featured Resources

 

This table lists key studies and review articles that examine the effect that the addition of palliative care has on overall patient costs. While results vary, the addition of palliative care typically either reduces overall costs or is cost neutral.

 

In the fall of 2018 the House and Senate passed the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (the SUPPORT Act)1 comprehensive legislation to address the opioid epidemic.

Photo of ACS CAN Volunteers at Advocacy Event to Support Cancer Research Funding

Research, Funding and Drug Development

Improvements in outcomes for cancer patients require continued research and innovation.  ACS CAN advocates for robust federal funding for cancer research, as well as research and drug approval policies that accelerate the development of new treatments while still ensuring patient safety.

Cancer registries provide high quality cancer data to inform policy at the local, state, and national levels. That National Program of Cancer Registries (NPCR) provides technical, operational, and financial support to most state cancer registries to help ensure data collected is representative of the U.S. population.

ACS CAN strongly believes that clinical trials are the key step towards advancing potential new cancer treatments from the research setting to the cancer care clinic, and that patient enrollment is critical to this success. Clinical trial matching improves enrollment by identifying a list of potential trials for which patients may be eligible. ACS CAN strongly supports NCI’s ongoing efforts to improve both its clinical trials reporting program (CTRP) database and functionalities within trials.cancer.gov. In this letter, we identify areas of need and potential opportunities for NCI to improve clinical trial matching.

Clinical trials are pivotal to advancements in cancer treatment, but patient enrollment in these trials remains a challenge. Clinical trial matching services facilitate patient enrollment in clinical trials by identifying potential trials for interested patients and their proxies (e.g., caregivers and providers), and in some cases by providing other support services such as educational materials or personnel who can answer questions or assist patients.

Photo of ACS CAN Volunteers participating in health care reform Lobby Day event

Access to Health Care

ACS CAN advocates for policies that provide access to treatments and services people with cancer need for their care - including those who may be newly diagnosed, in active treatment and cancer survivors.

ACS CAN submitted comments regarding the 2020 Proposed Notice of Benefit & Payment Parameters for the individual insurance market.

A Section 1115 Demonstration Waiver gives states flexibility to design and improve upon their Medicaid programs through pilot or demonstration projects.

ACS CAN submitted comments on the Medicare Part C and D Rule.

Photo of Making Strides Against Breast Cancer Event Participant

Prevention and Early Detection

ACS CAN advocates for public policies that can prevent nearly half of all cancer deaths by ensuring access to recommended cancer screenings, protecting the public from skin cancer risk, reducing tobacco use and exposure to secondhand smoke and supporting people in increasing physical activity, eating a healthy diet, and managing their weight.

Colorectal cancer is unique in that a person can be spared a cancer diagnosis if a polyp is found early and removed during the screening process. Right now, Medicare beneficiaries face a surprise bill when they wake up from a cancer screening that could save their life, thinking it was free. That's why it's so important to remove barriers to screening to ensure that all Americans have access.  

The greatest avoidable known risk factor for skin cancer is the use of indoor tanning devices. Yet, each year, approximately nine million Americans engage in indoor tanning. The desire for a tanned appearance causes many people, especially young adults and teenagers, to ignore the serious risks and health warnings and use indoor tanning devices.

The American Cancer Society Cancer Action Network (ACS CAN) advocates for public policies that will help reduce the risk of skin cancer associated with the use of indoor tanning devices.